DexCom, Inc. vs NIO Inc. — how do they compare? DexCom, Inc. trades at $77.49 (market cap $28.06B), while NIO Inc. trades at $5.1 (market cap $12.65B). The key difference: DexCom, Inc. is far larger — about 2.2× NIO Inc.'s market cap, and DexCom, Inc. is trading nearer its 52-week high, NIO Inc. nearer its low. Which is the better fit depends on your goals.
| DXCM | NIO | |
|---|---|---|
Market Cap | $28.06B | $12.65B |
Sector | Health | Consumer Cyclical |
52-Week High | $89.53 | $7.89 |
52-Week Low | $54.84 | $4.11 |
Enterprise Value | $27.03B | $11.88B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NIO trades at $5.02, up 1.83% today, showing resilience amid bearish technical signals. The company reported strong Q2 2026 vehicle deliveries with 62.9% year-over-year growth, while financials reveal ongoing losses with a net income margin of -9.09% for 2025. Analyst sentiment remains positive with 54% buy ratings, including a recent Goldman Sachs upgrade to Buy with a $7 target.
NIO presents a high-risk, high-reward opportunity with strong delivery growth offset by persistent profitability challenges. The path to profitability remains the key investment thesis, with recent margin improvements and premium vehicle mix providing potential upside. Significant risks include intense EV competition, cash burn, and regulatory uncertainties in the Chinese market.
Trailing returns across standard periods
Latest headlines on both assets
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →NIO Inc. manufactures and sells automobiles. The Company offers electric vehicles and parts, as well as provides battery charging services. NIO serves customers worldwide.
Read more on NIO →